Dr. Jan Wasley

Biography

Dr Jan Wasley's scientific background lies in organic and medicinal chemistry. He received his B.Sc. degree in chemistry in 1959 and his Ph.D. (synthesis of pyrroles, porphyrins and related macrocycles) in 1962 from Professor A.W. Johnson at the University of Nottingham, England. Following a postdoctoral fellowship (1962-1964) at the National Research Council of Canada, Dr. Wasley joined the Research Division of Geigy Pharmaceuticals in 1965 as a Senior Chemist, gradually holding positions of increasing responsibility within the Research Department at Ciba-Geigy drug discovery and drug development activities as Executive Director Research Support. Most recently he was responsible for identifying new technologies, Strategic Planning and managing external collaborations.  In 1993 Dr. Wasley joined Neurogen Corporation as Director of Chemistry and in 1995 took on the added responsibility of VP Business Development where he became involved in the development of Neurogen's Accelerated Intelligent Drug Design (AIDD) technologies. He retired from Neurogen in August 2001 and formed SimPharma LLC and has established an international client base over the past 11 years. In addition, Dr. Wasley  was appointed to the position of Chief Scientific Officer at the Institutes for Pharmaceutical Discovery, having joined the Affiliated Institute of Bioanalytics in 2001as Director before taking on the additional role of CSO of  all the  Institutes the following year. Dr. Wasley has more than 45 years experience in the design, discovery and development of novel drugs for a wide variety of diseases and has over 100 publications and patents in the area of medicinal chemistry. During that time he discovered/developed more than 25 drugs that reached advanced clinical or preclinical status. He has taught and lectured on drug design, discovery and development at the University of Connecticut and Wesleyan University and is a WWBoard Member for the Society of Concurrent Product Development. He has more than 90 publications and patents in the field of medicinal chemistry.

Research Interest

Bioinformatics & Systems Biology